Cite
Severe myelosuppression involving HPV‐B19 infection and NUDT15 polymorphisms during therapy for LCH.
MLA
Hosokawa, Hiroki, et al. “Severe Myelosuppression Involving HPV‐B19 Infection and NUDT15 Polymorphisms during Therapy for LCH.” Pediatrics International, vol. 65, no. 1, Jan. 2023, pp. 1–3. EBSCOhost, https://doi.org/10.1111/ped.15669.
APA
Hosokawa, H., Kitazawa, H., Akita, N., Yoshida, N., & Hama, A. (2023). Severe myelosuppression involving HPV‐B19 infection and NUDT15 polymorphisms during therapy for LCH. Pediatrics International, 65(1), 1–3. https://doi.org/10.1111/ped.15669
Chicago
Hosokawa, Hiroki, Hironobu Kitazawa, Nobuhiro Akita, Nao Yoshida, and Asahito Hama. 2023. “Severe Myelosuppression Involving HPV‐B19 Infection and NUDT15 Polymorphisms during Therapy for LCH.” Pediatrics International 65 (1): 1–3. doi:10.1111/ped.15669.